Cancer Center– A Cancer Center Designated by
the National Cancer Institute

Clinical Trials in the Category "Neuroblastoma"

Drug Intervention Trials that are Recruiting

Study Title
 Principal Investigator Disease Category
Combination Chemotherapy and Surgery With or Without Isotretinoin in Treating Young Patients With Neuroblastoma Dr. Neyssa Maria Marina
 Neuroblastoma
A Study of Pemetrexed in Children With Recurrent Cancer Dr. Neyssa Maria Marina
 Osteosarcoma
Neuroblastoma
Medulloblastoma
Comparing Two Different Myeloablation Therapies in Treating Young Patients Who Are Undergoing a Stem Cell Transplant for High-Risk Neuroblastoma Dr. Neyssa Marina
 Neuroblastoma
Intravenous Fenretinide in Treating Young Patients With Recurrent or Resistant Neuroblastoma Clare J. Twist M.D.
 Neuroblastoma
Irinotecan and Vincristine for Radiosensitization of 131I-MIBG Therapy for High-Risk Neuroblastoma Clare J. Twist M.D.
 Neuroblastoma
Ixabepilone in Treating Young Patients With Refractory Solid Tumors Dr. Neyssa Marina
 Sarcoma
Wilms Tumor
Neuroblastoma
Iodine I 131 Metaiodobenzylguanidine, Combination Chemotherapy, and Radiation Therapy in Treating Patients Who Are Undergoing an Autologous Peripheral Stem Cell or Bone Marrow Transplant for Relapsed or Refractory Neuroblastoma Clare J. Twist M.D.
 Neuroblastoma
Isotretinoin With or Without Monoclonal Antibody, Interleukin-2, and Sargramostim Following Stem Cell Transplantation in Treating Patients With Neuroblastoma Dr. Neyssa Marina
 Neuroblastoma
Melphalan and Buthionine Sulfoximine Followed by Stem Cell Transplantation in Children With Resistant or Recurrent Neuroblastoma Clare J. Twist M.D.
 Neuroblastoma



Trials not Recruiting

Study Title
 Principal Investigator Disease Category
Zoledronic Acid (ZOMETA) With Cyclophosphamide With Neuroblastoma and Cortical Bone Involvement
(No longer recruiting) 		Clare J. Twist M.D.
 Neuroblastoma
Vorinostat With or Without Isotretinoin in Treating Young Patients With Recurrent or Refractory Solid Tumors, Lymphoma, or Leukemia
(No longer recruiting) 		Dr. Neyssa Marina
 Leukemia
Lymphoma
Neuroblastoma
Medulloblastoma
hu14.18-Interleukin-2 Fusion Protein in Treating Young Patients With Recurrent or Refractory Neuroblastoma
(Completed) 		Dr. Neyssa Marina
 Neuroblastoma


The physicians of the Stanford Cancer Center are engaged in more than 250 clinical trials.  Contracts with some of our clinical trial sponsors prevent us from listing specific trial information on our web site. Please contact the Stanford Cancer Clinical Trials Office at 650-498-7061 for information about additional open clinical trials.

Stanford Medicine Resources:

Footer Links: